Sonoma Pharmaceuticals Inc. (SNOA)

$SNOA 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company's products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company'sproducts are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.

CEO

Amy Trombly

Exchange

NASDAQ

Website

www.sonomapharma.com

$17M

Total Revenue

20

Employees

$11M

Market Capitalization

-2.16

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 18925 2239 2.81 15.20 43.40
Organon & Co. OGN 8905 7891 -4.60 5.10 22.06
Arvinas Inc ARVN 3725 21 7.48 -22.56 -782.93
Tilray Inc TLRY 3241 564 1.08 -8.14 -66.49
ATAI Life Sciences N.V. ATAI 2272 20 4.78 -10.40 -932.88
Cronos Group Inc CRON 2097 57 1.32 -14.52 -258.59
Usana Health Sciences Inc USNA 2079 1254 4.73 14.98 11.09
NRX Pharmaceuticals Inc NRXP 1170 2321 0.45 5.05 9.91
Phathom Pharmaceuticals Inc PHAT 1033 7.01 -6.45 None
Phibro Animal Health Corp. PAHC 893 833 3.70 16.25 6.53
Intersect ENT Inc XENT 893 103 21.65 -13.01 -66.55
Edgewise Therapeutics Inc EWTX 796 2.70 -29.55 None
Fulcrum Therapeutics Inc FULC 711 15 8.62 -9.63 -481.07
Pliant Therapeutics Inc PLRX 614 13 2.51 -7.16 -613.56
Cyteir Therapeutics Inc CYT 596 3.20 -20.62 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 404 10 2.18 -7.38 -551.28
Chromadex Corp CDXC 394 62 9.92 -16.62 -37.51
Provention Bio Inc PRVB 377 2.53 -2.94 None
Rain Therapeutics Inc RAIN 355 413 2.19 -11.66 123.20
Verrica Pharmaceuticals Inc VRCA 325 12 6.57 -8.92 -301.45
Evolus Inc EOLS 310 77 4.10 -2.08 -171.53
Adicet Bio Inc ACET 280 9 1.22 -4.97 -603.06
Terns Pharmaceuticals Inc TERN 252 1.40 -7.30 None
Milestone Pharmaceuticals Inc MIST 219 15 1.23 -7.37 -215.93
Kaleido Biosciences Inc KLDO 184 1 4.11 -2.07 None
Citius Pharmaceuticals Inc CTXR 179 2.24 -7.81 None
scPharmaceuticals Inc SCPH 167 119 2.45 -5.52 -27.05
Eyenovia Inc EYEN 143 6 16.29 -7.31 -324.94
Aquestive Therapeutics Inc AQST 142 42 -2.95 -2.21 -152.73
LifeMD Inc LFMD 139 64 -22.39 -1.00 -133.55
Eton Pharmaceuticals Inc ETON 124 15 6.13 -10.10 -74.52
Osmotica Pharmaceuticals Plc OSMT 122 190 2.37 -1.31 -47.85
Kala Pharmaceuticals Inc KALA 119 11 1.53 -0.94 None
Xeris Biopharma Holdings Inc XERS 111 34 12.19 -1.44 -248.46
Odonate Therapeutics Inc ODT 110 1.39 -0.94 None
Anebulo Pharmaceuticals Inc ANEB 102 7.93 -2.58 None
Opiant Pharmaceuticals Inc OPNT 100 37 3.03 -96.15 -3.06
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Mannatech Inc MTEX 82 158 3.27 12.89 4.22
Natural Alternatives Internati NAII 80 179 1.07 7.90 6.03
India Globalization Capital In IGC 67 0 2.45 -7.60 -981.18
VYNE Therapeutics Inc VYNE 51 16 0.77 2.31 -554.66
Shineco Inc TYHT 44 3 2.17 -1.55 -159.60
Assertio Holdings Inc ASRT 36 117 0.49 -0.63 -38.05
Dermata Therapeutics Inc DRMA 36 -75.67 -7.32 None
Acasti Pharma Inc ACST 33 0 1.43 -1.66 -611.47
Nabriva Therapeutics Plc NBRV 29 12 0.88 -0.49 -452.55
Lexaria Bioscience Corp LEXX 27 1 3.76 -6.95 -445.15
Bio-Path Holdings Inc BPTH 26 0 1.19 -2.49 18.96
Reviva Pharmaceuticals Holding RVPH 25 1.41 -4.08 None
Baudax Bio Inc BXRX 25 1 -10.80 0.76 9.10
Trevi Therapeutics Inc TRVI 23 1.64 -0.66 None
Timber Pharmaceuticals Inc TMBR 20 0 8.79 0.68 -527.55
Hoth Therapeutics Inc HOTH 19 1.64 -2.02 None
Cyanotech Corp. CYAN 17 34 0.98 13.38 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.32 -2.16 -31.96

What Will Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Be Like After It Drops -136.6% From Its Highs?

4d ago, source: marketingsentinel

During the recent session, Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA)’s traded shares were 18.65 million, with the beta value ...

Sonoma Pharmaceuticals Inc. (SNOA) market price of $6.27 offers the impression of an exciting value play

1d ago, source: investchronicle

At the end of the latest market close, Sonoma Pharmaceuticals Inc. (SNOA) was valued at $5.94. In that particular session, Stock kicked-off at the price of $7.08 while reaching the peak value of $7.20 ...

Sonoma Pharmaceuticals Inc.’s (NASDAQ: SNOA) 5.56% Incline Frightens Investors Off The Stock

1d ago, source: stocksregister

Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) traded at $6.27 at close of the session on Friday, 10/15/21, made an upward move of 5.56% on its previous day’s price. Looking at the stock we see that its ...

Sonoma Pharmaceuticals Inc. (SNOA) Profit Margins posted -32.00% in the last twelve months: The key fundamentals to watch

4d ago, source: investchronicle

For the readers interested in the stock health of Sonoma Pharmaceuticals Inc. (SNOA). It is currently valued at $6.26. When the transactions were called off in the previous session, Stock hit the ...

Sonoma : Nanocyn Disinfectant & Sanitizer Approved By Australia With 15 Second COVID-19 Kill Time

4d ago, source: Business Insider

Sonoma Pharmaceuticals Inc. (SNOA) and its partner, the MicroSafe Group said in a statement. In Friday pre-market trade, SNOA was trading at $7.21 up $1.27 or 21.38%. The Australia has approved ...

Sonoma Pharmaceuticals Inc O8Z3

5d ago, source: Morningstar%2c Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO

4d ago, source: MSN

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) and its partner, the MicroSafe Group, announced that the Australian Therapeutic Goods Administration has approved extended claims for Nanocyn ...

Swift, Uneventful Sonoma County Winegrape Harvest Is A Welcome Change And May Signal Return Of Market Balance

6d ago, source: PR Newswire

In a year best described as a "cold start to a warm, fast finish," reports from throughout Sonoma County indicate that the harvest was a little early, the grape yield appears to be slightly ...

Your Portfolio